Interstitial lung disease due to anti-TNF use in the treatment of psoriasis
An. bras. dermatol
;
96(4): 447-450, July-Aug. 2021. graf
Artículo
en Inglés
| LILACS
| ID: biblio-1285096
ABSTRACT
Abstract Psoriasis is a chronic inflammatory disease that affects the skin variably, according to genetic and environmental factors. Some patients may benefit from systemic treatment with immunobiological agents, drugs that can be accompanied by several adverse effects. A case of a 58-year-old patient undergoing treatment for psoriasis with adalimumab for five years is reported. Alterations compatible with interstitial pneumonia were detected with important regression after adalimumab discontinuation. This case is relevant due to the scarcity of reports on late pulmonary adverse effect of anti-TNF treatment of psoriasis.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Psoriasis
/
Enfermedades Pulmonares Intersticiales
Límite:
Humanos
Idioma:
Inglés
Revista:
An. bras. dermatol
Asunto de la revista:
Dermatologia
Año:
2021
Tipo del documento:
Artículo
País de afiliación:
Brasil
Institución/País de afiliación:
Hospital Universitário Onofre Lopes/BR
Similares
MEDLINE
...
LILACS
LIS